Treatment of CFS & Fibromyalgia With Recovery Factors

Not Applicable

Completed

• Conditions: Fibromyalgia; Chronic Fatigue Syndrome

• Registration Number: NCT04381793
• Lead Sponsor: Practitioners Alliance Network

Brief Summary

The study will explore if Recovery Factors improve symptoms in fibromyalgia and chronic fatigue syndrome

Detailed Description

Subjects will receive four tablets twice a day (three times a day for five day loading dose), taking the treatment for 5 - 6 weeks. Subjects will receive four tablets twice a day (three times a day for five day loading dose), taking the treatment for 5 - 6 weeks. The treatment is a unique nutritional peptide mix derived from porcine serum

Study Timeline

• Study Start: 2019-05-20
• Status Verified: 2020-02
• Study First Submitted: 2020-05-06
• Study First Submitted QC: 2020-05-06
• Study First Posted: 2020-05-11
• Primary Completion: 2020-07-04
• Study Completion: 2020-07-04
• Last Update Submitted: 2020-10-15
• Last Update Posted: 2020-10-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 43

Inclusion Criteria

• Meet ACR 2010 amended Fibromyalgia criteria or CDC CFS Criteria Overall well being score of 5 of less (on 0-10 VAS)

Exclusion Criteria

Pregnant Clotting disorders

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
VAS	6 weeks	Composite VAS (1-10) for Fatigue, Pain, Cognition, Sleep and overall well-being

Secondary Outcome Measures

Name	Time	Method
antibody titres	10 weeks	Total IgG and IgG 1-4 subsets
FIQ-R	6 weeks	Fibromyalgia severity scale

Trial Locations

Locations (1)

Jacob Teitelbaum MD; 🇺🇸 Kailua, Hawaii, United States